David O. Freedman, MD
To the Editor: The need for adequate immunity to measles in international travelers, outlined by Hill and Pearson (1) and von Reyn and Saviteer (2), is clear cut. These authors have not adequately emphasized, however, the logistic or financial impact that the administration of a live-virus vaccine such as the measles vaccine will have on the pretravel immunization protocols used by travel clinics. Well-defined administration guidelines for the spacing of live-antigen preparations with other live-virus preparations or with immune globulin (a biological given to virtually all travelers to the developing world) will-with the addition of measles vaccine-ultimately lead to the
Freedman DO. Measles Vaccine and Travelers. Ann Intern Med. 1990;112:475–476. doi: 10.7326/0003-4819-76-3-112-6-475
Download citation file:
Published: Ann Intern Med. 1990;112(6):475-476.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use